SCHEMBL9019705

SCHEMBL9019705

CC(=O)OCC(COC(C)=O)OCCl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 5/20 0.39
LMNA P02545 2/20 0.39
HSD17B10 Q99714 1/20 0.39
PRKCA P17252 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
CHRM5 P08912 2/20 0.32
CHRM1 P11229 2/20 0.32
CHRM3 P20309 2/20 0.32
PGR P06401 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
HTR1A P08908 1/20 0.32
CHRNB2 P17787 1/20 0.32
TBXA2R P21731 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9828135 0.91 AR (0.42) ARTDP1ALDH1A1LMNAHSD17B10
SCHEMBL9827309 0.90 AR (0.37) ARTDP1ALDH1A1LMNAHSD17B10
SCHEMBL2466001 0.79 TDP1 (0.42) ARTDP1ALDH1A1LMNAHSD17B10
SCHEMBL12582664 0.79 ALDH1A1 (0.52) ARTDP1ALDH1A1LMNAHSD17B10
SCHEMBL9170510 0.77 TDP1 (0.41) ARTDP1ALDH1A1LMNAHSD17B10
SCHEMBL2562190 0.77 AR (0.41) ARTDP1ALDH1A1LMNAHSD17B10
SCHEMBL2611104 0.76 ALDH1A1 (0.46) ARTDP1ALDH1A1LMNAHSD17B10
SCHEMBL14040213 0.76 TDP1 (0.39) ARTDP1ALDH1A1LMNAHSD17B10
SCHEMBL4282945 0.76 AR (0.57) ARTDP1ALDH1A1LMNAHSD17B10
Triacetin SCHEMBL19859036 0.76 AR (0.50) ARTDP1ALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0452680-B1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AG (DE) 1996-11-06 EP disclosed
EP-0452680-A1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AKTIENGESELLSCHAFT (DE) 1991-10-23 EP disclosed
US-4897479-A VIRICIDES FOR HERPES SIMPLEX MERCK & CO., INC. (US) 1990-01-30 US disclosed
EP-0138656-B1 CYCLIC PYROPHOSPHATES OF PURINE AND PYRIMIDINE ACYCLONUCLEOSIDES, THEIR PREPARATION AND THEIR APPLICATION IN ANTI-VIRAL COMPOSITIONS MERCK & CO. INC. (US) 1989-09-27 EP disclosed
US-4816447-A HERPES VIRUS MERCK & CO., INC. (US) 1989-03-28 US disclosed
EP-0074306-B1 ANTI-VIRAL GUANINE DERIVATIVES MERCK & CO. INC. (US) 1988-06-01 EP disclosed
US-4670424-A Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides MERCK & CO., INC. (US) 1987-06-02 US disclosed
EP-0165164-A1 Anti-viral compounds, their preparation and anti-viral compositions MERCK & CO. INC. (US) 1985-12-18 EP disclosed
EP-0138683-A2 Purine derivatives, their application in anti-viral compositions MERCK & CO. INC. (US) 1985-04-24 EP disclosed
EP-0138656-A1 Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides, their preparation and their application in anti-viral compositions MERCK & CO. INC. (US) 1985-04-24 EP disclosed
EP-0074306-A2 Anti-viral guanine derivatives MERCK & CO. INC. (US) 1983-03-16 EP disclosed